Venmax Drugs and Pharmaceuticals Ltd — Important, 07-08-2026: Company Update

Venmax Drugs & Pharmaceuticals confirmed no deviation in using funds from its preferential issue. The company stated that Rs. 8.37 crore was utilized for working capital and Rs. 0.20 crore for general corporate purposes and business acquisition, out of the total Rs. 20.05 crore planned. A total of Rs. 12.69 crore and Rs. 1.84 crore has been received from investors. This update assures shareholders that the raised capital is deployed as originally intended.